FOLICET Drug Patent Profile
When do Folicet patents expire, and when can generic versions of Folicet launch?
Folicet is a drug marketed by Mission Pharma and is included in one NDA.
The generic ingredient in FOLICET is folic acid. There is one drug master file entry for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the folic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Folicet
A generic version of FOLICET was approved as folic acid by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FOLICET?
- What are the global sales for FOLICET?
- What is Average Wholesale Price for FOLICET?
Summary for FOLICET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 141 |
| DailyMed Link: | FOLICET at DailyMed |
US Patents and Regulatory Information for FOLICET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | FOLICET | folic acid | TABLET;ORAL | 087438-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
